Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

Attachment

• Notification of trade_skjema - Magnus Tolleshaug

You May Also Be Interested In

• Campine delivers resilient €47 million EBITDA in H1 2026 despite sharp normalization in metal prices
• TP: Monthly Information Regarding Shares and Voting Rights
• ATAP and ERPHealth Launch America's First Labor-Led, Outcomes-Based Behavioral Health High Performance Network